urban-gro, Inc. Common Stock

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite falling around 15 points on Thursday. The Dow traded up 0.06% to 39,785.29 while the NASDAQ fell 0.13% to 16,383.85. The S&P 500 also rose, gaining, 0.10% to 5,253.70. Check This Out: Jim Cramer Likes Crown Castle, But Can't Recommend Archer Aviation: It Has 'No Earnings Power'   Leading and Lagging Sectors   Energy shares jumped by 1.1% on Thursday. In trading on Thursday, communication services shares fell by 0.2%.   Top Headline   Shares of MSC Industrial Direct Co., Inc. (NYSE: MSM) fell over 2% during Thursday’s session after the company reported mixed second-quarter results. MSC Industrial Direct reported second-quarter FY24 net sales decline of 2.7% Y/Y to $935.3 million, missing the consensus of $946.5 million. Adjusted EPS of $1.18, down 18.6%, beating the consensus of $1.16. MSC Industrial reiterated the outlook for FY24 ADS growth of 0%-5%, adjusted operating margin of 12% – 12.8%, and an operating cash flow conversion of more than 125%.   Equities Trading UP   Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares shot up 384% to $22.98 after the company announced it acquired a Phase 2-ready anti-IL-1β mAb, which it refers to as AVTX-009, through the acquisition of privately held AlmataBio. The company also announced a private placement financing of up to $185 million. Shares of Xilio Therapeutics, Inc. (NASDAQ:

Related tickers: MSM, DTST, AVTX, UGRO, XLO, BDRX, PMEC.

Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss. Kodiak Sciences posted a quarterly loss of $1.13 per share, compared to market expectations for a loss of 77 cents per share. Kodiak Sciences shares dipped 19.9% to $5.97 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares jumped 430% to $25.35 after the company announced it acquired a Phase 2-ready anti-IL-1β mAb, which it refers to as AVTX-009, through the acquisition of privately held AlmataBio. The company also announced a private placement financing of up to $185 million. Xilio Therapeutics, Inc. (NASDAQ: XLO) gained 146% to $1.58 after the company announced an exclusive license agreement with Gilead Sciences for a tumor-activated IL-12 program. The company announced a $11.3 million private placement equity financing. Biodexa Pharmaceuticals Plc (NASDAQ: BDRX) shares climbed 80% to $1.5395. Biodexa's MTX110 showed promise in extending life expectancy against aggressive brain cancers. Ontrak, Inc. (NASDAQ: OTRK) gained 55% to $0.9239. Binah Capital Group, Inc. (NASDAQ: BCG) gained 48% to $14.05 after dipping more than 20% on Wednesday. Kidpik Corp. (NASDAQ: PIK) gained 40.7% to $4.5999. Kidpik recently regained compliance with the Nasdaq minimum bid price requirement. Allego N.V. (NASDAQ: ALLG) rose 32.8% to $1.7650. Akanda Corp. (NASDAQ: AKAN) gained 28% to $0.2053 after the company announced a plan to evaluate opportunities in Bitcoin, Blockchain and AI applications in the cannabis industry. Destiny Tech100 Inc. (NASDAQ: DXYZ) rose 26% to $22.15. REX American Resources Corporation (NYSE: REX) gained 23.2% to $54.15 following upbeat earnings. Nutriband Inc. (NASDAQ: NTRB) gained 23% to $4.98. Nutriband recently provided a clinical and regulatory path overview for its AVERSA Fentanyl patch. Summit Therapeutics Inc. (NASDAQ: ...

Related tickers: DXYZ, RH, MTTR, MARA, CZOO, XLO, OPK, BCG, MLKN, MSTR, KOD, PIK, PRST, NTRB, BRZE, CCL, NCNA, ALLG, EL, HUT, AKAN, CC, STRO, MRNO, DNA, GMDA, BDRX, REX, HKIT, MVLA, TNXP, AVTX, SEZL, ALT, UGRO, PMEC, GCTS, NKLA, ABTS, DTST, SOBR, CERO, SMMT, OTRK, RDDT, XXII, KTRA.